SCHEMBL5653660

SCHEMBL5653660

O=C1OC(COC(=O)c2ccccc2)C=C1c1cccc(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
ATM Q13315 1/20 0.40
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
HPGD P15428 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.37
GAA P10253 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
PPM1B O75688 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5653859 0.89 L3MBTL1 (0.38) SMN1; SMN2LMNAL3MBTL1TDP1ATM
SCHEMBL5652924 0.86 MEN1 (0.42) L3MBTL1NPC1RAB9AALDH1A1MEN1
SCHEMBL5654683 0.86 ALDH1A1 (0.37) TDP1NPC1RAB9AALDH1A1KDM4E
SCHEMBL5655563 0.82 CYP2D6 (0.40) SMN1; SMN2L3MBTL1TDP1NPC1RAB9A
SCHEMBL5652657 0.81 CSNK2A2 (0.37) LMNAMEN1MAPTKMT2A
SCHEMBL5652451 0.81 CYP1A2 (0.44) LMNAL3MBTL1HPGDALDH1A1KDM4E
SCHEMBL5653480 0.81 SLC6A2 (0.38) TDP1RAB9AALDH1A1KDM4EPPM1B
SCHEMBL5654672 0.81 ALDH1A1 (0.32) SMN1; SMN2LMNATDP1NPC1RAB9A
SCHEMBL5653658 0.80 SMN1; SMN2 (0.39) SMN1; SMN2LMNAL3MBTL1TDP1NPC1
SCHEMBL14366922 0.80 TDP1 (0.32) L3MBTL1TDP1ATMALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259948-A1 Compounds with antifungal properties and process thereof ADH5, GK, AKR1C3 SMN1; SMN2 4689/4885LMNA 4005/4885L3MBTL1 3159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.